Back to resultsIncreased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
Primary Purpose
Venous Thromboembolism
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
electronic alerts
Sponsored by
About this trial
This is an interventional health services research trial for Venous Thromboembolism focused on measuring venous thromboembolism/prevention & control
Eligibility Criteria
Inclusion criteria:
- all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
- staying at least 24 h in a ward
Exclusion criteria:
- outpatients,
- ward without CPOE,
- patients transferred from an intervention to a control ward and vice versa
Sites / Locations
- University Hospital Zurich, Center for Clinical Research
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
roll out of eAlerts
Arm Description
Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Outcomes
Primary Outcome Measures
Rate of prophylaxis against venous thromboembolism
patients with prophylaxis/total patients
Secondary Outcome Measures
ordering time after admission or transfer of a patient
time when physicians order a venous thromboembolism prophylaxis
acceptance of the eAlerts
survey of compliant and incompliant physicians
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01598805
Brief Title
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
Official Title
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
Study Type
Interventional
2. Study Status
Record Verification Date
November 2012
Overall Recruitment Status
Completed
Study Start Date
June 2012 (undefined)
Primary Completion Date
September 2012 (Actual)
Study Completion Date
September 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Zurich
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.
Detailed Description
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Venous Thromboembolism
Keywords
venous thromboembolism/prevention & control
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
N/A
Enrollment
10000 (Actual)
8. Arms, Groups, and Interventions
Arm Title
roll out of eAlerts
Arm Type
Experimental
Arm Description
Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Intervention Type
Behavioral
Intervention Name(s)
electronic alerts
Other Intervention Name(s)
eAlert
Intervention Description
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Primary Outcome Measure Information:
Title
Rate of prophylaxis against venous thromboembolism
Description
patients with prophylaxis/total patients
Time Frame
3 months
Secondary Outcome Measure Information:
Title
ordering time after admission or transfer of a patient
Description
time when physicians order a venous thromboembolism prophylaxis
Time Frame
3 months
Title
acceptance of the eAlerts
Description
survey of compliant and incompliant physicians
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
staying at least 24 h in a ward
Exclusion criteria:
outpatients,
ward without CPOE,
patients transferred from an intervention to a control ward and vice versa
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juerg Blaser, Prof. PhD
Organizational Affiliation
University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Zurich, Center for Clinical Research
City
Zurich
Country
Switzerland
12. IPD Sharing Statement
Learn more about this trial
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
We'll reach out to this number within 24 hrs